ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

Interview with FDA’s Richard Pazdur

October 30, 2009

Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned.

November 5, 2004

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999